| PhIP | 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine |
| Ago4 | Argonaute 4 |
| Anxa1 | Annexin A1 |
| Atp5po | Mitochondrial ATP synthase subunit O |
| Bmp2 | Bone morphogenetic protein 2 |
| cCASP-3 | Cleaved caspase-3 |
| Cebpa | CCAAT/enhancer-binding protein alpha |
| Ces | Carboxylic ester hydrolase |
| Cox7a1 | Mitochondrial cytochrome c oxidase polypeptide 7a1 |
| CYP | Cytochrome P450 |
| Ddhd2 | DDHD domain-containing protein 2 |
| DDR | DNA damage response |
| DEGs | Differentially expressed genes |
| Fabp4 | Fatty acid binding protein 4 |
| F-CON | Female control group |
| Fis1 | Mitochondrial fission 1 |
| F-PhIP | Female PhIP group |
| GO | Gene ontology |
| HAAs | Heterocyclic aromatic amines |
| Hif1a | Hypoxia-inducible factor 1-alpha |
| IPA | Ingenuity pathway analysis |
| Lipe | Hormone-sensitive lipase |
| Lpl | Lipoprotein lipase |
| M-CON | Male control group |
| M-PhIP | Male PhIP group |
| mtDNA | Mitochondrial DNA |
| Ndufa5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 |
| OXPHOS | Oxidative phosphorylation |
| PANTHER | Protein annotation through evolutionary relationships |
| p-ATR | Phosphorylated ataxia telangiectasia and Rad3 related |
| p-BRCA1 | Phosphorylated breast cancer type 1 |
| p-γH2AX | Phosphorylated H2A histone family member X |
| p-p53 | Phosphorylated tumor protein p53 |
| qPCR | Quantitative real-time PCR |
| RIN | RNA integrity number |
| RNAseq | RNA sequencing |
| Timm13 | Mitochondrial import inner membrane translocase subunit Tim13 |